WO2024121818 - METHOD OF TREATING HEART FAILURE IN SUBJECTS WITH PERSISTENT INFLAMMATION
National phase entry:
Publication Number
WO/2024/121818
Publication Date
13.06.2024
International Application No.
PCT/IB2023/062427
International Filing Date
08.12.2023
Title **
[English]
METHOD OF TREATING HEART FAILURE IN SUBJECTS WITH PERSISTENT INFLAMMATION
[French]
MÉTHODE DE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE CHEZ DES SUJETS AYANT UNE INFLAMMATION PERSISTANTE
Applicants **
MESOBLAST INTERNATIONAL SARL
Inventors
ITESCU, Silviu
SIMMONS, Paul
HAYES, Jack
HORST, Justin
SEE, Fiona
BOROW, Kenneth
Priority Data
63/386,876
09.12.2022
US
63/386,878
09.12.2022
US
63/486,792
24.02.2023
US
63/507,009
08.06.2023
US
63/507,013
08.06.2023
US
63/513,777
14.07.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4834 | |
| EPO | Filing, Examination, Granting | 63030 | |
| Japan | Filing, Examination, Granting | 4066 | |
| South Korea | Filing, Examination, Granting | 6113 | |
| USA | Filing, Examination, Granting | 18990 |
Total:
97,033
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to cellular compositions with anti-inflammatory properties and use of the same in methods for treating and/or preventing progressive heart failure.[French]
La présente invention concerne des compositions cellulaires ayant des propriétés anti-inflammatoires et leur utilisation dans des méthodes de traitement et/ou de prévention d'une insuffisance cardiaque progressive.